Search

Your search keyword '"Chronic obstructive lung disease -- Care and treatment"' showing total 541 results
Start Over Descriptor "Chronic obstructive lung disease -- Care and treatment" Publication Year Range Last 10 years
541 results on '"Chronic obstructive lung disease -- Care and treatment"'

1. Harbour BioMed submits IND application for HBM9378/SKB378 to China NMPA to treat chronic obstructive pulmonary disease

Subjects
Care and treatment, Product development, Lung cancer -- Care and treatment, Diseases -- Care and treatment, Chronic obstructive lung disease -- Care and treatment, Biological products -- Product development, Lung diseases, Obstructive -- Care and treatment
Abstract

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announced the submission of an IND application to [...]

Published
2024

2. Data on Coronavirus Reported by Researchers at Kyung Hee University [Prospective Proof-of-concept Observational Research About Traditional Herbal Preparation Treatment for Chronic Obstructive Pulmonary Disease (Reset-copd-1)]

Subjects
Diseases, Care and treatment, Dyphylline, Diseases -- Care and treatment -- South Korea, Coronaviruses, Chronic obstructive lung disease -- Care and treatment, Herbal medicine, Patient compliance, Lung diseases, Obstructive -- Care and treatment, Medicine, Botanic, Medicine, Herbal
Abstract

2024 NOV 5 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- A new study on RNA Viruses - Coronavirus is now available. According to news [...]

Published
2024

3. What Interventions Do Physical Therapists Provide for Patients With Cardiorespiratory Conditions, Neurological Conditions, and Conditions Requiring Acute Hospital Care? A Systematic Review

Author

Zadro, Joshua R., Cheng, Sonia, O'Keeffe, Mary, and Maher, Christopher G.

Subjects
Parkinson disease -- Care and treatment, Evidence-based medicine -- Usage, Physical therapy -- Usage, Chronic obstructive lung disease -- Care and treatment, Physical therapists -- Usage, Stroke -- Care and treatment, Health
Abstract

Objective. The aim of this systematic review was to determine what percentages of physical therapists provide interventions that are of high value, low value, or unknown value for cardiorespiratory conditions, neurological conditions, or conditions requiring acute hospital care. Whether an intervention was considered high or low value was determined by reference to guidelines or systematic reviews. Methods. Searches of numerous databases were performed by combining terms synonymous with 'practice patterns' and 'physical therapy' until April 2018. Studies that investigated what interventions physical therapists provide for any cardiorespiratory condition, neurological condition, or condition requiring acute hospital care through surveys and audits of clinical notes were included. Through the use of medians and interquartile ranges, the percentages of physical therapists who provided interventions that were of high value, low value, or unknown value were summarized. Results. Twenty-six studies were included. The median percentages of physical therapists who provided interventions of high, low, and unknown value for chronic obstructive pulmonary disease ranged from 78% to 96%, 67% to 100%, and 56% to 91%, respectively. These percentages ranged from 61% to 97%, 87% to 98%, and 83% to 98% for adults who were critically ill in intensive care units; 70% to 93%, 38% to 50%, and 8% to 95% before or after cardiac/thoracic surgery; 25% to 96%, 23% to 84%, and 96% for acute stroke; and 11% (high value) and 13% (unknown value) for Parkinson disease, respectively. Conclusions. This review found patterns of physical therapist practice for cardiorespiratory conditions, neurological conditions, and conditions requiring acute hospital care that were both evidence based and not evidence based. A concern is that a substantial percentage of physical therapists provided interventions that were of low or unknown value despite the availability of high-value interventions. Impact. This systematic review is the first, to our knowledge, to summarize the percentage of physical therapist treatment choices that were high versus low value for cardiorespiratory conditions, neurological conditions, and conditions requiring acute hospital care. The findings highlight areas of practice where low-value care could be replaced with high-value care--such as in the management of patients who have chronic obstructive pulmonary disease or who are in intensive care--and identify an urgent need to develop and test strategies to ensure that patients with these conditions receive the interventions most likely to improve their outcomes., High- and low-value health care is a concept receiving substantial attention in many fields of medicine. (1) High-value care refers to an intervention for which evidence suggests it provides a [...]

Published
2020
Full Text
View/download PDF

4. The Effect of Breathing Retraining Using Metronome-Based Acoustic Feedback on Exercise Endurance in COPD: A Randomized Trial

Author

Collins, Eileen G., Jelinek, Christine, O'Connell, Susan, Butler, Jolene, Reda, Domenic, and Laghi, Franco

Subjects
Clinical trials -- Analysis, Chronic obstructive lung disease -- Care and treatment, Exercise -- Health aspects, Health
Abstract

Background During exercise-training patients with chronic obstructive pulmonary disease (COPD) can entrain their breathing pattern to visual-feedback cues as to achieve a slower respiratory rate and prolong exhalation. The result is an improvement in exercise tolerance and a reduction in dynamic hyperinflation. Acoustic stimuli, including metronome-generated acoustic stimuli, can entrain human movements. Accordingly, we hypothesized that exercise duration and dynamic hyperinflation would be less after exercise-training plus breathing-retraining using a metronome-based acoustic-feedback system than after exercise-training alone. Methods Of 205 patients with COPD [FEV.sub.1 = 44 ± 16% predicted (± SD)] recruited, 119 were randomly assigned to exercise-training plus breathing-retraining using acoustic feedback (n = 58) or exercise-training alone (n = 61). Patients exercised on a treadmill thrice-weekly for 12 weeks. Before and at completion of training, patients underwent constant-load treadmill testing with inspiratory capacity measures every 2 min. Results At completion of training, improvements in exercise duration in the breathing-retraining plus exercise-training and exercise-training alone groups were similar (p = 0.35). At isotime, inspiratory capacity increased (less exercise-induced dynamic hyperinflation) by 3% (p = 0.001) in the breathing-retraining plus exercise-training group and remained unchanged in the exercise-alone group. The between-group change in inspiratory capacity, however, was not significant (p = 0.08). Conclusions In patients with COPD, breathing-retraining using a metronome-based acoustic feedback did not result in improved exercise endurance or decreased dynamic hyperinflation when compared to exercise-training alone. Trial registry: ClinicalTrials.gov; No.: NCT NCT01009099; URL: http://www.clinicaltrials.gov http://www.clinicaltrials.gov, Author(s): Eileen G. Collins [sup.1] [sup.2] , Christine Jelinek [sup.2] , Susan O'Connell [sup.2] , Jolene Butler [sup.2] , Domenic Reda [sup.3] [sup.4] , Franco Laghi [sup.5] [sup.6] Author Affiliations: [...]

Published
2019
Full Text
View/download PDF

5. Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients

Author

Fernandes, Juliana Ruiz, Marques da Silva, Cibele Cristine Berto, da Silva, Aline Grandi, de Carvalho Pinto, Regina Maria, da Silva Duarte, Alberto José, Carvalho, Celso Ricardo, and Benard, Gil

Subjects
Lymphocytes -- Research, Chronic obstructive lung disease -- Care and treatment, Cytomegalovirus -- Research, Haemophilus influenzae -- Research, Exercise -- Health aspects, T cells -- Research, Health
Abstract

Exercise training has been shown to reduce symptoms and exacerbations in COPD patients; however, the exercise effect on patients' immune response is poorly known. We thus verified if an exercise program (EP) impacted on proliferative T cell response of COPD patients. Fourteen non-O.sub.2 dependent COPD patients on standard treatment were studied. EP consisted in 24 sessions of aerobic and muscular training. Peripheral blood mononuclear cells were stimulated with the mitogen phytohemagglutinin and antigens from Haemophilus influenzae and cytomegalovirus, and the lymphocyte proliferative response (LPR) was assessed through the expression of Ki67 before and after the EP. The Quality of life [COPD assessment test (CAT)], dyspnea [(modified Medical Research Council scale (mMRC)], and 6-min walk distance were also assessed. The EP program increased significantly the LPR of TCD4+ lymphocytes to phytohemagglutinin and cytomegalovirus and H. influenzae antigens, but with TCD8+ lymphocytes the increase was less marked. Consistent with this, a higher proportion of TCD8+ than TCD4+ cells did not express the costimulatory molecule CD28. The EP also resulted in improvement of the quality of life, dyspnea, and physical capacity. The improvement in TCD4+ cell function may represent an additional mechanism through which the EP results in less exacerbations and hospitalizations., Author(s): Juliana Ruiz Fernandes [sup.1] , Cibele Cristine Berto Marques da Silva [sup.2] , Aline Grandi da Silva [sup.2] , Regina Maria de Carvalho Pinto [sup.3] , Alberto José da [...]

Published
2018
Full Text
View/download PDF

6. Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies

Author

Kerwin, Edward, Ferguson, Gary T., Sanjar, Shahin, Goodin, Thomas, Yadao, Anthony, Fogel, Robert, and Maitra, Samopriyo

Subjects
Clinical trials -- Usage, Chronic obstructive lung disease -- Care and treatment, Health
Abstract

Purpose To compare the efficacy and safety of two long-acting dual bronchodilator combinations: indacaterol/glycopyrrolate (IND/GLY) versus umeclidinium/vilanterol (UMEC/VI). Methods Studies A2349 and A2350 were replicate, randomized, double-blind, double-dummy, active-controlled, cross-over studies in patients with moderate-to-severe COPD. Patients were randomized to sequential 12-week treatments of twice-daily IND/GLY 27.5/15.6 [mu]g and once-daily UMEC/VI 62.5/25 [mu]g, each separated by a 3-week washout. The primary objective was to demonstrate non-inferiority of IND/GLY compared with UMEC/VI in terms of the 24-h forced expiratory volume in 1 s profile at week 12 (FEV.sub.1 AUC.sub.0-24). Rescue medication use, symptom control, and safety were assessed throughout. Results Both treatments delivered substantial bronchodilation over 12 weeks, with improvements in FEV.sub.1 AUC.sub.0-24h at week 12 of 232 and 185 mL for IND/GLY, and 244 and 203 mL with UMEC/VI in Studies A2349 and A2350, respectively. The primary efficacy objective of non-inferiority of IND/GLY relative to UMEC/VI was not met as the lower bound of the confidence interval for the LS treatment comparison was below the pre-specified non-inferiority margin of -20 mL in both studies: -26.9 and -34.2 mL, respectively (LS mean between-treatment differences: -11.5 and -18.2 mL). Both drugs were well tolerated, with AE profiles consistent with their respective prescribing information. Conclusions IND/GLY and UMEC/VI provided clinically meaningful and comparable bronchodilation. Non-inferiority of IND/GLY to UMEC/VI could not be declared although between-treatment differences were not clinically relevant. The data support the use of IND/GLY as an efficacious and well tolerated treatment option in patients with COPD. (ClinicalTrials.gov NCT02487446 and NCT02487498), Author(s): Edward Kerwin [sup.1] , Gary T. Ferguson [sup.2] , Shahin Sanjar [sup.3] , Thomas Goodin [sup.3] , Anthony Yadao [sup.4] , Robert Fogel [sup.4] , Samopriyo Maitra [sup.5] , [...]

Published
2017
Full Text
View/download PDF

7. An overview of exacerbations of chronic obstructive pulmonary disease: Can tests of small airways' function guide diagnosis and management?

Author

Alobaidi, Nowaf, Stockley, James, Stockley, Robert, and Sapey, Elizabeth

Subjects
Medical tests, Chronic obstructive lung disease -- Care and treatment, Death, Lung diseases, Respiratory tract diseases, Diseases, Health
Abstract

Byline: Nowaf. Alobaidi, James. Stockley, Robert. Stockley, Elizabeth. Sapey Chronic obstructive pulmonary disease (COPD) is common and debilitating. Most patients with COPD experience intermittent, acute deterioration in symptoms which require [...]

Published
2020

8. Creating an interprofessional team and discharge planning guide to decrease hospital readmissions for COPD

Author

Saunier, Danielle T.

Subjects
United States. Centers for Disease Control and Prevention, Evidence-based medicine, Chronic obstructive lung disease -- Care and treatment, Patient compliance, Respiratory system agents, Hospital admission and discharge, Nurses, Health
Abstract

An interprofessional team was created to address high hospital readmission rates for chronic obstructive pulmonary disease (COPD). The team developed a discharge planning guide to ensure inpatient care was less fragmented. Educational efforts focused on improving nurse knowledge of COPD and appropriate technique for inhaler use., Chronic obstructive pulmonary disease (COPD) is a chronic lung disease that is irreversible and incurable. However, it can be managed according to guidelines of the Global Initiative for Chronic Obstructive [...]

Published
2017

9. EU approves AstraZeneca's Trixeo Aerosphere to treat moderate to severe COPD

Subjects
AstraZeneca PLC, Chronic obstructive lung disease -- Care and treatment, Pharmaceutical industry, Drug approval, Pharmaceuticals and cosmetics industries, European Union
Abstract

AstraZeneca's Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been approved in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who [...]

Published
2020

10. IoMT technology devices immensely helping treat COPD patients during COVID-19 pandemic: Experts

Subjects
Epidemics -- Care and treatment, Chronic obstructive lung disease -- Care and treatment, COVID-19 -- Care and treatment, Pharmaceuticals and cosmetics industries
Abstract

Byline: Shardul Nautiyal Internet of Medical Things (IoMT) technology devices are increasingly helping treatment of chronic obstructive pulmonary disease (COPD) patients as they reduce the need of taking an appointment [...]

Published
2020

11. Researchers at Institut Universitaire de Cardiologie et de Pneumologie de Quebec Zero in on Chronic Obstructive Pulmonary Disease (Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the ...)

Subjects
Physical fitness -- Analysis, Chronic obstructive lung disease -- Care and treatment, Health
Abstract

2020 NOV 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on chronic obstructive pulmonary disease have been presented. According to [...]

Published
2020

12. Recent Findings from CIRO Provides New Insights into Chronic Obstructive Pulmonary Disease (Effects of Exercise-based Interventions On Fall Risk and Balance In Patients With Chronic Obstructive Pulmonary Disease a Systematic Review)

Subjects
Physical fitness, Chronic obstructive lung disease -- Care and treatment, Accidental falls, Medical research, Health
Abstract

2020 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Lung Diseases and Conditions - Chronic Obstructive Pulmonary [...]

Published
2020

13. New Chronic Obstructive Pulmonary Disease Study Findings Have Been Reported from Imperial College London (Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis)

Subjects
Physical fitness -- Analysis, Chronic obstructive lung disease -- Care and treatment, Respiratory system agents -- Analysis, Medical research -- Analysis, Health, University of London. Imperial College of Science and Technology
Abstract

2020 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on chronic obstructive pulmonary disease have been presented. According to [...]

Published
2020

14. Data from First Affiliated Hospital of Guangzhou Medical University Advance Knowledge in Chronic Obstructive Pulmonary Disease [High-dose N-acetylcysteine for long-term, regular treatment of early-stage chronic obstructive pulmonary disease ...]

Subjects
Acetylcysteine -- Dosage and administration, Physical fitness, Chronic obstructive lung disease -- Care and treatment, Medical research, Health
Abstract

2020 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on chronic obstructive pulmonary disease have been published. According [...]

Published
2020

15. Data from Liaoning University of Traditional Chinese Medicine Provide New Insights into Chronic Obstructive Pulmonary Disease (Preventive and therapeutic effectiveness of Sanfu acupoint herbal patching for chronic obstructive pulmonary disease ...)

Subjects
Physical fitness -- Health aspects, Chronic obstructive lung disease -- Care and treatment, Acupuncture -- Health aspects, Health
Abstract

2020 AUG 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Lung Diseases and Conditions - Chronic Obstructive Pulmonary Disease [...]

Published
2020

16. Data on Chronic Obstructive Pulmonary Disease Discussed by Researchers at Guy's and St Thomas' NHS Foundation Trust (Nonantibiotic Pharmacological Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations)

Subjects
Physical fitness, Chronic obstructive lung disease -- Care and treatment, Medical research, Health
Abstract

2020 AUG 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Lung Diseases and Conditions - Chronic Obstructive [...]

Published
2020

17. Findings from State University of New York (SUNY) Buffalo Provides New Data about Chronic Obstructive Pulmonary Disease (Triple Therapy versus Dual or Monotherapy with Long-acting Bronchodilators for COPD: A Systematic Review and Meta-Analysis)

Subjects
Physical fitness -- Analysis, Chronic obstructive lung disease -- Care and treatment, Respiratory system agents -- Analysis, Medical research -- Analysis, Health, State University of New York
Abstract

2020 AUG 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Lung Diseases and Conditions - Chronic Obstructive [...]

Published
2020

18. AstraZeneca reports Breztri Aerosphere approved in U.S. for COPD

Subjects
AstraZeneca PLC, Chronic obstructive lung disease -- Care and treatment, Respiratory system agents, Pharmaceutical industry, Business, News, opinion and commentary
Abstract

AstraZeneca's Breztri Aerosphere has been approved in the U.S. for the maintenance treatment of patients with chronic obstructive pulmonary disease, or COPD, the company announced. Breztri Aerosphere is not indicated [...]

Published
2020

19. AstraZeneca,COs phase III ETHOS trial of triple-combo therapy Breztri Aerosphere shows significantly reduced rate of moderate or severe exacerbations in COPD

Subjects
Clinical trials, Chronic obstructive lung disease -- Care and treatment, Respiratory system agents, Pharmaceuticals and cosmetics industries, Bevespi Aerosphere (Medication) -- Product development
Abstract

Full results from the positive phase III ETHOS trial showed AstraZenecaÇÖs triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) demonstrated a statistically significant reduction in the rate of moderate or severe exacerbations [...]

Published
2020

20. Glenmark Introduces 3-in-1 Inhaler Therapy for COPD in India, Promising Reduction in Risk of Severe Attacks and Improvement in Lung Function

Subjects
Glenmark Pharmaceuticals Ltd., Physical fitness, Chronic obstructive lung disease -- Care and treatment, Patient compliance, Respiratory system agents, Pharmaceutical industry, Lung diseases, Glucocorticoids, Diseases, Inhalers, Obesity, Fluticasone, Corticosteroid drugs, Retirement benefits, Editors, Health
Abstract

2020 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, announced the [...]

Published
2020

21. Glenmark Pharma launches 3-in-1 inhaler therapy for COPD in India

Subjects
Chronic obstructive lung disease -- Care and treatment, Inhalers, Fluticasone, Respiratory system agents, Lung diseases, Corticosteroid drugs, Retirement benefits, Glucocorticoids, Diseases, Pharmaceuticals and cosmetics industries
Abstract

Byline: Our Bureau Glenmark Pharmaceuticals announced the launch of a single inhaler triple therapy AIRZ-FF - a combination of two bronchodilators, glycopyrronium & formoterol and the inhalation corticosteroid fluticasone propionate, [...]

Published
2020

22. Arcutis announces inclusion of children in Phase 3 trials of ARQ-151

Subjects
United States. Food and Drug Administration, Clinical trials, Chronic obstructive lung disease -- Care and treatment, Psoriasis -- Care and treatment, Roflumilast, Lung diseases, Diseases, Children, Business, News, opinion and commentary
Abstract

Arcutis Biotherapeutics announced that, at the request of the U.S. Food and Drug Administration, Arcutis has submitted a protocol amendment to the FDA to include children ages 2 to 11 [...]

Published
2020

23. New Chronic Obstructive Pulmonary Disease Study Findings Have Been Reported by Researchers at Intermountain Medical Center [Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive ...]

Subjects
Physical fitness, Medical centers, Chronic obstructive lung disease -- Care and treatment, Medical research, Mortality, Obesity, Lung diseases, Finance, Editors, Respiratory tract diseases, Diseases, Health
Abstract

2020 FEB 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Lung Diseases and Conditions - Chronic Obstructive Pulmonary [...]

Published
2020

24. The effect of the presence and severity of bronchiectasis on the respiratory functions, exercise capacity, dyspnea perception, and quality of life in patients with chronic obstructive pulmonary disease

Author

Sahin, Hulya, Naz, Ilknur, Susam, Seher, Erbaycu, Ahmet, and Olcay, Serhan

Subjects
Chronic obstructive lung disease -- Care and treatment, Medical research, Bronchiectasis -- Care and treatment, Lung diseases, Respiratory tract diseases, Health
Abstract

Byline: Hulya. Sahin, Ilknur. Naz, Seher. Susam, Ahmet. Erbaycu, Serhan. Olcay BACKGROUND: Bronchiectasis is common in patients with advanced chronic obstructive pulmonary disease (COPD) and adversely affects the patients' clinical [...]

Published
2020

27. Primary Care Providers' Views on Using Lung Age as an Aid to Smoking Cessation Counseling for Patients with Chronic Obstructive Pulmonary Disease

Author

Parker, Donna R., Eltinge, Sarah, Rafferty, Caitlin, Eaton, Charles B., Clarke, Jennifer G., and Goldman, Roberta E.

Subjects
Chronic obstructive lung disease -- Care and treatment, Smoking cessation -- Methods, Medical personnel -- Beliefs, opinions and attitudes -- Practice, Health counseling -- Methods, Health
Abstract

Purpose Smoking cessation is the primary goal for managing patients with chronic obstructive pulmonary disease (COPD) who smoke. However, previous studies have demonstrated poor cessation rates. The 'lung age' concept (an estimate of the age at which the FEV.sub.1 would be considered normal) was developed to present spirometry data in an understandable format and to serve as a tool to encourage smokers to quit. Primary care physicians' (PCPs) views of using lung age to help COPD patients to quit smoking were assessed. Methods Post-intervention interviews were conducted with PCPs in the U.S. who participated in the randomized clinical trial, 'Translating the GOLD COPD Guidelines into Primary Care Practice.' Results 29 physicians completed the interview. Themes identified during interviews included: general usefulness of lung age for smoking cessation counseling, ease of understanding the concept, impact on patients' thoughts of quitting smoking, and comparison to FEV.sub.1. Most providers found lung age easy to communicate. Moreover, some found the tool to be less judgmental for smoking cessation and others remarked on the merits of having a simple, tangible number to discuss with their patients. However, some expressed doubt over the long-term benefits of lung age and several others thought that there might be a potential backfire for healthy smokers if their lung age was [less than or equal to] to their chronological age. Conclusions This study suggests that lung age was well received by the majority of PCPs and appears feasible to use with COPD patients who smoke. However, further investigation in needed to explore COPD patients' perspectives of obtaining their lung age to help motivate them to quit in randomized clinical trials., Author(s): Donna R. Parker[sup.1] [sup.2] [sup.3] , Sarah Eltinge[sup.3] , Caitlin Rafferty[sup.3] , Charles B. Eaton[sup.1] [sup.2] [sup.3] , Jennifer G. Clarke[sup.3] , Roberta E. Goldman[sup.1] [sup.3] Author Affiliations: (1) [...]

Published
2015
Full Text
View/download PDF

28. How to improve care, hit quality metrics for COPD patients: In the age of value-based care, helping patients manage this chronic condition becomes more important than ever

Author

Eramo, Lisa A.

Subjects
Medicare -- Analysis -- Economic aspects -- Forecasts and trends, Chronic obstructive lung disease -- Care and treatment, Patients -- Education -- Evaluation, Market trend/market analysis, Business, Economics, Health care industry
Abstract

PATIENTS AREN'T the only ones who benefit from chronic obstructive pulmonary disease (COPD) treatment. Positive COPD outcomes also help physicians drive more money to their bottom line. That's because by [...]

Published
2017

29. COPD

Author

Yawn, Barbara P.

Subjects
Chronic obstructive lung disease -- Care and treatment, Smoking cessation -- Prevention, Business, Economics, Health care industry
Abstract

Winter is not a good time for most people with chronic obstructive pulmonary disease (COPD). During the winter months, rates of COPD exacerbations, hospitalizations and related deaths increase, as do [...]

Published
2017

30. Coding case studies COPD

Author

Dowling, Renee

Subjects
Chronic obstructive lung disease -- Care and treatment, Business, Economics, Health care industry
Abstract

In the medical billing and coding field, getting paid requires accurate documentation and selecting the correct codes. In our Coding Case Studies, we will explore the correct coding for a [...]

Published
2020

31. AstraZeneca gets Chinese approval for triple-combo therapy, budesonide/glycopyrronium/formoterol fumarate to treat COPD

Subjects
AstraZeneca PLC, Formoterol, Chronic obstructive lung disease -- Care and treatment, Pharmaceutical industry, Medical supplies, Technology, Respiratory system agents, Lung diseases, Pharmaceuticals and cosmetics industries, Bevespi Aerosphere (Medication)
Abstract

AstraZeneca announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This is the first approval by the National Medical Products [...]

Published
2019

32. Data on Chronic Obstructive Pulmonary Disease Described by Researchers at National Heart and Lung Institute (Antiviral immunity is impaired in COPD patients with frequent exacerbations)

Subjects
Physical fitness, Antiviral agents, Chronic obstructive lung disease -- Care and treatment, Disease susceptibility -- Care and treatment, Medical research, Obesity, Lung diseases, Anopheles, Editors, Medical societies, Health
Abstract

2019 DEC 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Lung Diseases and Conditions - Chronic Obstructive [...]

Published
2019

33. ALung Updates on Continued Progress Towards Completion of 2 Landmark Pivotal Trials

Subjects
Chronic obstructive lung disease -- Care and treatment, Technology, Lung diseases, Clinical trials, Arts and entertainment industries
Abstract

ALung Technologies reported the recent achievement of two significant clinical trial milestones, enrollment of 60 plus patients in its U.S. based VENT-AVOID clinical trial and greater than 400 patients in [...]

Published
2019

34. Bayer, BWH & MGH open joint lab for research of new treatments for chronic lung diseases

Subjects
Bayer AG, Chronic obstructive lung disease -- Care and treatment, Pharmaceutical industry, Scientists, Lung diseases, Respiratory tract diseases, Pharmaceuticals and cosmetics industries, Massachusetts General Hospital
Abstract

Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH), announced the launch of a joint lab to research new drug candidates to treat [...]

Published
2019

35. AstraZeneca Phase 3 ETHOS trial meets primary endpoint

Subjects
AstraZeneca PLC -- Product development, Clinical trials, Chronic obstructive lung disease -- Care and treatment, Pharmaceutical industry -- Product development, Respiratory system agents, Lung diseases, Business, News, opinion and commentary
Abstract

AstraZeneca announced results from the Phase 3 ETHOS trial for triple-combination therapy PT010 in patients with moderate to very severe chronic obstructive pulmonary disease, or COPD. At the standard budesonide [...]

Published
2019

36. Glenmark to promote, commercialize Novartis' 3 respiratory products to treat COPD in Brazil

Subjects
Novartis AG, Chronic obstructive lung disease -- Care and treatment, Indacaterol, Pharmaceutical industry, Bromine compounds, Glycopyrrolate, Lung diseases, Pharmaceuticals and cosmetics industries
Abstract

Byline: Our Bureau Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, announced that its Brazilian subsidiary, Glenmark Farmaceutica Ltd has entered into an exclusive partnership agreement with Novartis Biosciences [...]

Published
2019

37. HELPING CANADIANS MANAGE LUNG DISEASE ONE BREATH AT A TIME

Author

Connors, Cheryl

Subjects
Allied health personnel -- Practice, Chronic obstructive lung disease -- Care and treatment, Education, Lung diseases, Spirometry, Respiratory tract diseases, Asthma, General interest, News, opinion and commentary
Abstract

John learned that he had COPD (chronic obstructive pulmonary disease) after taking a breathing test called spirometry at the Toronto Western Hospital's Asthma and Airway Centre. His respirologist, Dr. Ken [...]

Published
2019

38. New Chronic Obstructive Pulmonary Disease Data Have Been Reported by Researchers at Texas A&M University (Adoption and adherence to chronic obstructive pulmonary disease GOLD guidelines in a primary care setting)

Subjects
Physical fitness, Chronic obstructive lung disease -- Care and treatment, Medical research, Death, Obesity, Lung diseases, Editors, Respiratory tract diseases, Health
Abstract

2019 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Lung Diseases and Conditions - Chronic Obstructive [...]

Published
2019

39. Studies from Nanchang University Describe New Findings in Oral Candidiasis (Risks of Budesonide/formoterol for the Treatment of Stable Copd: a Meta-analysis)

Subjects
Formoterol -- Usage, Chronic obstructive lung disease -- Care and treatment, Oral candidiasis -- Research -- Drug therapy -- Risk factors, Obesity, Mycoses, Medical research, Candidiasis, Physical fitness, Editors, Health
Abstract

2019 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Mouth Diseases and Conditions - Oral Candidiasis have [...]

Published
2019

40. New Combination Therapy Findings from University of Rome Discussed (Adding a Lama To Ics/laba Therapy a Meta-analysis of Triple Combination Therapy In Copd)

Subjects
Clinical trials -- Analysis, Meta-analysis -- Usage, Chronic obstructive lung disease -- Care and treatment, Adrenergic beta-agonists -- Usage, Databases, Obesity, Corticosteroid drugs, Glucocorticoids, Physical fitness, Editors, Health
Abstract

2019 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Combination Therapy. According [...]

Published
2019

41. Findings from Case Western Reserve University in the Area of Mycobacterium avium Reported (Optimization of In Vitro Mycobacterium Avium and Mycobacterium Intracellulare Growth Assays for Therapeutic Development)

Subjects
Chronic obstructive lung disease -- Care and treatment, Mycobacterium avium -- Research, Obesity, Respiratory tract diseases, Bacteria, Immunocompromised host, Lung diseases, Mycobacterium avium complex, HIV patients, Physical fitness, Cystic fibrosis, Infection, AIDS (Disease), Fibrosis, Editors, Medical research, Health
Abstract

2019 APR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Gram-Positive Bacteria - Mycobacterium avium have been published. [...]

Published
2019

42. Institute of Advanced Lung Disease for chronic lung disease management launched in Hyderabad

Subjects
Chronic obstructive lung disease -- Care and treatment, Tuberculosis, Respiratory tract diseases, Death, Pneumonia, Asthma, Lung diseases, Pharmaceuticals and cosmetics industries
Abstract

Byline: Our Bureau Aiming to provide advanced treatment for a complete range of pulmonary diseases, an 'Institute of Advanced Lung Disease' was launched in Hyderabad. The Institute would provide highly [...]

Published
2019

43. 'Combination Therapy For Copd' in Patent Application Approval Process (USPTO 20190046433)

Subjects
Chiesi Farmaceutici S.p.A. -- Intellectual property, Chronic obstructive lung disease -- Care and treatment, Patent licensing, Pharmaceutical industry -- Intellectual property, Obesity, Physical fitness, Editors, Health
Abstract

2019 MAR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent application by the inventors BONELLI, Sauro (Parma, IT); USBERTI, Francesca [...]

Published
2019

44. Telerehabilitation for chronic obstructive pulmonary disease patients: An underrecognized management in tertiary care

Author

Bairapareddy, Kalyana, Chandrasekaran, Baskaran, and Agarwal, Umang

Subjects
Telemedicine -- Methods, Chronic obstructive lung disease -- Care and treatment, Rehabilitation -- Technology application, Technology application, Health
Abstract

Byline: Kalyana. Bairapareddy, Baskaran. Chandrasekaran, Umang. Agarwal Pulmonary rehabilitation (PR) is proved to be best supportive management in chronic obstructive pulmonary disease (COPD) individuals. The literature claims the reduction of [...]

Published
2018

45. New recommendations for managing COPD discussed

Author

Skolnik, Neil and Matthews, Jeffery

Subjects
Chronic obstructive lung disease -- Care and treatment, Practice guidelines (Medicine), Health, American Thoracic Society
Abstract

The American Thoracic Society released a guideline on the pharmacologic management of chronic obstructive pulmonary disease (COPD) after formulating specific questions to be answered using rigorous GRADE (Grading of Recommendations [...]

Published
2020

46. New hope for COPD patients possible with in-home device

Subjects
Evidence-based medicine, Chronic obstructive lung disease -- Care and treatment, Death, Lung diseases, Respiratory insufficiency, Hypercapnia, Adult respiratory distress syndrome, Diseases, News, opinion and commentary
Abstract

COPD is a chronic lung disease that makes it difficult to breathe. COPD is the third leading cause of death in the US, with more than 15 million people currently [...]

Published
2020

47. New Respiratory Medicine Study Findings Have Been Reported from Suny Downstate Medicine Center (Chronic Cigarette Smoke Exposure Subdues PP2A Activity by Enhancing Expression of the Oncogene CIP2A)

Subjects
Chronic obstructive lung disease -- Care and treatment, Gene expression -- Research, Pulmonary medicine -- Usage -- Research, Health
Abstract

2018 DEC 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Health and Medicine - Respiratory Medicine. According [...]

Published
2018

48. New Drug Delivery Systems Findings Reported from University of Sydney (Pulmonary drug delivery to older people)

Subjects
Chronic obstructive lung disease -- Care and treatment, Drug delivery systems -- Usage, Elderly -- Health aspects, Obesity, Asthma, Lung diseases, Gerontology, Physical fitness, Respiratory system agents, Editors, Drugs, Health, University of Sydney -- Reports
Abstract

2018 DEC 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Drugs and Therapies - Drug Delivery Systems. [...]

Published
2018

49. Investigators from Yonsei University Target Obstructive Lung Disease (Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease)

Subjects
Atrial fibrillation -- Care and treatment, Chronic obstructive lung disease -- Care and treatment, Obesity, Respiratory tract diseases, Fibrillation, Lung diseases, Physical fitness, Editors, Medical research, Health
Abstract

2018 DEC 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Lung Diseases and Conditions - Obstructive Lung Disease [...]

Published
2018

50. Data on Opioids Reported by Researchers at Sunnybrook Health Sciences Center (End-of-Life Strategies among Patients with Advanced Chronic Obstructive Pulmonary Disease)

Subjects
Opioids -- Usage, Palliative care -- Methods, Chronic obstructive lung disease -- Care and treatment, Obesity, Respiratory tract diseases, Death, Lung diseases, Physical fitness, Patient care, Editors, Health
Abstract

2018 DEC 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Opioids are presented in a new report. According to [...]

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results